The possible connection between the Jenssen vaccine and the thromboembolic events is now being reviewed by a European company.
The European Medicines Agency (EMA) announced on April 9 that they’re reviewing the possible connection between Johnson & Johnson’s vaccine and the blood blotting cases reported in patients.
The company is responsible for regulating drugs for the European Union and is now working on discovering if there’s a link between the six women who became severely ill after vaccination. The women experienced unusual blood clots, and for one of them, the event was fatal.
But until further information from EMA about this situation, it’s still uncertain if the unfortunate event was caused by the Johnson & Johnson vaccine or not.
Make sure to also check: Do Not Worry About This When Getting Vaccinated, Fauci Says.
